BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 28087116)

  • 1. Application of whole exome sequencing in elucidating the phenotype and genotype spectrum of junctional epidermolysis bullosa: A preliminary experience of a tertiary care centre in India.
    Yenamandra VK; Vellarikkal SK; Kumar M; Chowdhury MR; Jayarajan R; Verma A; Scaria V; Sivasubbu S; Ray SB; Dinda AK; Kabra M; Kaur P; Sharma VK; Sethuraman G
    J Dermatol Sci; 2017 Apr; 86(1):30-36. PubMed ID: 28087116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-Phenotype Correlation in Junctional Epidermolysis Bullosa: Signposts to Severity.
    Wen D; Hunjan M; Bardhan A; Harper N; Ogboli M; Ozoemena L; Liu L; Fine JD; Chapple I; Balacco DL; Heagerty A
    J Invest Dermatol; 2024 Jun; 144(6):1334-1343.e14. PubMed ID: 38157931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next generation sequencing identifies double homozygous mutations in two distinct genes (EXPH5 and COL17A1) in a patient with concomitant simplex and junctional epidermolysis bullosa.
    Vahidnezhad H; Youssefian L; Saeidian AH; Touati A; Sotoudeh S; Jazayeri A; Guy A; Lovell PA; Liu L; Kariminejad A; McGrath JA; Zeinali S; Uitto J
    Hum Mutat; 2018 Oct; 39(10):1349-1354. PubMed ID: 30016581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Junctional epidermolysis bullosa in the Middle East: clinical and genetic studies in a series of consanguineous families.
    Nakano A; Lestringant GG; Paperna T; Bergman R; Gershoni R; Frossard P; Kanaan M; Meneguzzi G; Richard G; Pfendner E; Uitto J; Pulkkinen L; Sprecher E
    J Am Acad Dermatol; 2002 Apr; 46(4):510-6. PubMed ID: 11907499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of phenotypic variability in junctional epidermolysis bullosa.
    Kiritsi D; Kern JS; Schumann H; Kohlhase J; Has C; Bruckner-Tuderman L
    J Med Genet; 2011 Jul; 48(7):450-7. PubMed ID: 21357940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal dominant junctional epidermolysis bullosa.
    Almaani N; Liu L; Dopping-Hepenstal PJ; Lovell PA; Lai-Cheong JE; Graham RM; Mellerio JE; McGrath JA
    Br J Dermatol; 2009 May; 160(5):1094-7. PubMed ID: 19120338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-Phenotype Correlations of Dystrophic Epidermolysis Bullosa in India: Experience from a Tertiary Care Centre.
    Yenamandra VK; Vellarikkal SK; Chowdhury MR; Jayarajan R; Verma A; Scaria V; Sivasubbu S; Ray SB; Dinda AK; Kabra M; Sharma VK; Sethuraman G
    Acta Derm Venereol; 2018 Oct; 98(9):873-879. PubMed ID: 29963685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herlitz junctional epidermolysis bullosa: diagnostic features, mutational profile, incidence and population carrier frequency in the Netherlands.
    Yuen WY; Lemmink HH; van Dijk-Bos KK; Sinke RJ; Jonkman MF
    Br J Dermatol; 2011 Dec; 165(6):1314-22. PubMed ID: 21801158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Novel COL17A1 Compound Heterozygous Mutation in a Chinese Girl with Non-Herlitz Junctional Epidermolysis Bullosa.
    Yao YY; Zhang Y; Xie XH; Chen L; Zhu F; Zhou M
    Curr Med Sci; 2020 Aug; 40(4):795-800. PubMed ID: 32862392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laminin 332 in junctional epidermolysis bullosa.
    Kiritsi D; Has C; Bruckner-Tuderman L
    Cell Adh Migr; 2013; 7(1):135-41. PubMed ID: 23076207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominance of the recurrent mutation R635X in the LAMB3 gene in European patients with Herlitz junctional epidermolysis bullosa has implications for mutation detection strategy.
    Pulkkinen L; Meneguzzi G; McGrath JA; Xu Y; Blanchet-Bardon C; Ortonne JP; Christiano AM; Uitto J
    J Invest Dermatol; 1997 Aug; 109(2):232-7. PubMed ID: 9242513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digenic junctional epidermolysis bullosa: mutations in COL17A1 and LAMB3 genes.
    Floeth M; Bruckner-Tuderman L
    Am J Hum Genet; 1999 Dec; 65(6):1530-7. PubMed ID: 10577906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laminin-5 mutational analysis in an Italian cohort of patients with junctional epidermolysis bullosa.
    Posteraro P; De Luca N; Meneguzzi G; El Hachem M; Angelo C; Gobello T; Tadini G; Zambruno G; Castiglia D
    J Invest Dermatol; 2004 Oct; 123(4):639-48. PubMed ID: 15373767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-exome sequencing improves mutation detection in a diagnostic epidermolysis bullosa laboratory.
    Takeichi T; Liu L; Fong K; Ozoemena L; McMillan JR; Salam A; Campbell P; Akiyama M; Mellerio JE; McLean WH; Simpson MA; McGrath JA
    Br J Dermatol; 2015 Jan; 172(1):94-100. PubMed ID: 24947307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular identification of collagen 17a1 as a major genetic modifier of laminin gamma 2 mutation-induced junctional epidermolysis bullosa in mice.
    Sproule TJ; Bubier JA; Grandi FC; Sun VZ; Philip VM; McPhee CG; Adkins EB; Sundberg JP; Roopenian DC
    PLoS Genet; 2014 Feb; 10(2):e1004068. PubMed ID: 24550734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa.
    Kivirikko S; McGrath JA; Baudoin C; Aberdam D; Ciatti S; Dunnill MG; McMillan JR; Eady RA; Ortonne JP; Meneguzzi G
    Hum Mol Genet; 1995 May; 4(5):959-62. PubMed ID: 7633458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herlitz junctional epidermolysis bullosa.
    Laimer M; Lanschuetzer CM; Diem A; Bauer JW
    Dermatol Clin; 2010 Jan; 28(1):55-60. PubMed ID: 19945616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the COL17A1 in non-Herlitz junctional epidermolysis bullosa and amelogenesis imperfecta.
    Nakamura H; Sawamura D; Goto M; Nakamura H; Kida M; Ariga T; Sakiyama Y; Tomizawa K; Mitsui H; Tamaki K; Shimizu H
    Int J Mol Med; 2006 Aug; 18(2):333-7. PubMed ID: 16820943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laminin 5 mutations in junctional epidermolysis bullosa: molecular basis of Herlitz vs. non-Herlitz phenotypes.
    Nakano A; Chao SC; Pulkkinen L; Murrell D; Bruckner-Tuderman L; Pfendner E; Uitto J
    Hum Genet; 2002 Jan; 110(1):41-51. PubMed ID: 11810295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermal eosinophilic infiltrate in junctional epidermolysis bullosa.
    Saraiya A; Yang CS; Kim J; Bercovitch L; Robinson-Bostom L; Telang G
    J Cutan Pathol; 2015 Aug; 42(8):559-63. PubMed ID: 25950805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.